Luis Malave Joins Palyon Corporation as CEO
August 24, 2010
Insulet Announces Departure of Chief Operating Officer
August 18, 2010
Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
August 17, 2010
DRAFT - CONFIDENTIAL
AMARIN REPORTS Q2 2010 RESULTS -MARINE trial results due early 2011; ANCHOR trial >50% randomized - Conference call today
August 10, 2010
Amarin’s Amr101 Pivotal Phase 3 Marine Clinical Trial Completes Patient Enrollment And Randomization - Trial Guidance Positively Updated
August 10, 2010
Eamonn Hobbs Accepts Appointment as Chairman of the Board of Directors of Cappella
June 22, 2010
David Blossom joins Cappella as Vice President, Commercial Operations
June 14, 2010
Amarin Reports Q1 2010 Results
May 13, 2010
Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
December 02, 2009
Cappella, Inc. Announces Initiation of Sideguard 3
November 16, 2009
Amarin Appoints John F. Thero as Chief Financial Officer
November 06, 2009
Amarin Appoints Medpace As Cro For Two Phase 3 Cardiovascular Trials
October 19, 2009
Amarin Announces Completion Of $70 Million Private Placement
October 19, 2009
Amarin Announces $70 Million Private Placement
October 13, 2009
Amarin Announces Changes to Its Board And Management Team
October 13, 2009
Cappella Inc. Secures $17.3 Million Series C Investment
June 15, 2009
Nextech Venture participates in the $24m financing of Palyon Medical
May 19, 2009
Palyon Medical Corporation Secures $21 Million Series A Investment
April 29, 2009
Opsona Therapheutics Closes €18M Funding
February 18, 2009
Amarin Proceeding to Phase 3 with AMR101 for Hypertriglyceridemia
July 22, 2008
Amarin announces private placement for up to $60 million
May 14, 2008
Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm
April 29, 2008
Copyright © 2008-2010, Fountain HP. Designed and developed by
Web Design Sligo
WSI Web Excel
67
